Lenz HJ - Search Results

1

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.

Manegold P, Lai KKY, Wu Y, Teo JL, Lenz HJ, Genyk YS, Pandol SJ, Wu K, Lin DP, Chen Y, Nguyen C, Zhao Y, Kahn M. Manegold P, et al. Among authors: lenz hj. Cancers (Basel). 2018 Mar 29;10(4):95. doi: 10.3390/cancers10040095. Cancers (Basel). 2018. PMID: 29596326 Free PMC article.

2

Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.

Pohl A, Zhang W, Ning Y, Manegold PC, Lurje G, Lenz HJ. Pohl A, et al. Among authors: lenz hj. Oncology (Williston Park). 2008 Apr 15;22(4):456-62; discussion 462-3, 467-8, 474 passim. Oncology (Williston Park). 2008. PMID: 18472617 Free article. Review.

3

Stem cells in colon cancer.

Pohl A, Lurje G, Kahn M, Lenz HJ. Pohl A, et al. Among authors: lenz hj. Clin Colorectal Cancer. 2008 Mar;7(2):92-8. doi: 10.3816/CCC.2008.n.012. Clin Colorectal Cancer. 2008. PMID: 18501067 Review.

4

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.

Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ. Lurje G, et al. Among authors: lenz hj. Pharmacogenet Genomics. 2009 Feb;19(2):95-102. doi: 10.1097/FPC.0b013e32831a9ad1. Pharmacogenet Genomics. 2009. PMID: 18987561

5

Pharmacogenomics and -genetics in colorectal cancer.

Pohl A, Lurje G, Manegold PC, Lenz HJ. Pohl A, et al. Among authors: lenz hj. Adv Drug Deliv Rev. 2009 May 20;61(5):375-80. doi: 10.1016/j.addr.2008.10.002. Epub 2008 Dec 3. Adv Drug Deliv Rev. 2009. PMID: 19100300 Review.

6

Thymidylate synthase gene variations: predictive and prognostic markers.

Lurje G, Manegold PC, Ning Y, Pohl A, Zhang W, Lenz HJ. Lurje G, et al. Among authors: lenz hj. Mol Cancer Ther. 2009 May;8(5):1000-7. doi: 10.1158/1535-7163.MCT-08-0219. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383851 Review.

7

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

LaBonte MJ, Manegold PC, Wilson PM, Fazzone W, Louie SG, Lenz HJ, Ladner RD. LaBonte MJ, et al. Among authors: lenz hj. Int J Cancer. 2009 Dec 15;125(12):2957-69. doi: 10.1002/ijc.24658. Int J Cancer. 2009. PMID: 19536776 Free article.

8

Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.

Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, Winder T, Yang D, LaBonte MJ, Wilson PM, Ladner RD, Lenz HJ. Ning Y, et al. Among authors: lenz hj. Int J Cancer. 2011 May 1;128(9):2038-49. doi: 10.1002/ijc.25562. Int J Cancer. 2011. PMID: 20648559 Free PMC article.

9

Common cancer stem cell gene variants predict colon cancer recurrence.

Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, LaBonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, El-Khoueiry A, Kahn M, Lenz HJ. Gerger A, et al. Among authors: lenz hj. Clin Cancer Res. 2011 Nov 1;17(21):6934-43. doi: 10.1158/1078-0432.CCR-11-1180. Epub 2011 Sep 14. Clin Cancer Res. 2011. PMID: 21918173

10

The potential of targeting Wnt/β-catenin in colon cancer.

Sebio A, Kahn M, Lenz HJ. Sebio A, et al. Among authors: lenz hj. Expert Opin Ther Targets. 2014 Jun;18(6):611-5. doi: 10.1517/14728222.2014.906580. Epub 2014 Apr 5. Expert Opin Ther Targets. 2014. PMID: 24702624 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

682 results

Search Page